These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 6438851

  • 1. Phase II study of ifosfamide combined with Mesna uroprotection in advanced non-small-cell lung carcinoma and other solid tumors.
    Nobile MT, Rosso R, Brema F, Cinquegrana A, Santi L.
    Tumori; 1984 Oct 31; 70(5):433-7. PubMed ID: 6438851
    [Abstract] [Full Text] [Related]

  • 2. A phase I trial of ifosfamide, mesna, and cisplatin in advanced non-small cell lung cancer. A cancer and leukemia group B study.
    Graziano SL, Herndon JE, Richards F, DiFino S, Modeas C, Duggan DB, Green MR.
    Cancer; 1993 Jul 01; 72(1):62-8. PubMed ID: 8389667
    [Abstract] [Full Text] [Related]

  • 3. Oral ifosfamide/mesna versus intravenous ifosfamide/mesna in non-small-cell lung cancer: a randomized phase II trial of the EORTC lung cancer cooperative group.
    Manegold C, Drings P, Pawinski A, Lentz MA, van Glabbeke M, van Zandwijk N, Bachmann P, Schnaars Y, Skacel Z, Zatloukal P, Dolensky J, Jackevicius A, Petruzelka L, Giaccone G.
    Ann Oncol; 1996 Aug 01; 7(6):637-9. PubMed ID: 8879380
    [Abstract] [Full Text] [Related]

  • 4. Doxorubicin, ifosfamide, and dacarbazine (AID) with mesna uroprotection for advanced untreated sarcoma: a phase I study.
    Elias AD, Antman KH.
    Cancer Treat Rep; 1986 Jul 01; 70(7):827-33. PubMed ID: 3087617
    [Abstract] [Full Text] [Related]

  • 5. A randomized phase II study of ifosfamide/mesna/cisplatin plus G-CSF or etoposide/cisplatin plus G-CSF in advanced non-small cell lung cancer: a Cancer and Leukemia Group B study.
    Graziano SL, Valone FH, Herndon JE, Crawford J, Richards F, Rege VB, Clamon G, Green MR.
    Lung Cancer; 1996 Jun 01; 14(2-3):315-29. PubMed ID: 8794413
    [Abstract] [Full Text] [Related]

  • 6. A phase I study of high-dose ifosfamide and escalating doses of carboplatin with autologous bone marrow support.
    Elias AD, Ayash LJ, Eder JP, Wheeler C, Deary J, Weissman L, Schryber S, Hunt M, Critchlow J, Schnipper L.
    J Clin Oncol; 1991 Feb 01; 9(2):320-7. PubMed ID: 1846407
    [Abstract] [Full Text] [Related]

  • 7. Ifosfamide and mesna: response and toxicity at standard- and high-dose schedules.
    Antman KH, Elias A, Ryan L.
    Semin Oncol; 1990 Apr 01; 17(2 Suppl 4):68-73. PubMed ID: 2110386
    [Abstract] [Full Text] [Related]

  • 8. Ifosfamide and mesna for the treatment of advanced squamous cell head and neck cancer. A GETLAC study.
    Cervellino JC, Araujo CE, Pirisi C, Francia A, Cerruti R.
    Oncology; 1991 Apr 01; 48(2):89-92. PubMed ID: 1900124
    [Abstract] [Full Text] [Related]

  • 9. Chemotherapy with high dose ifosfamide/mesna plus cisplatin for the treatment of ovarian cancer: a study of the Grupo de Estudio y Tratamiento Latino-Americano del Cancer.
    Araujo CE, Cervellino JC, Pirisi C, Pannunzio O, Callegari J.
    J Surg Oncol; 1991 Mar 01; 46(3):198-202. PubMed ID: 1901372
    [Abstract] [Full Text] [Related]

  • 10. A phase II study of ifosfamide/mesna with doxorubicin for adult soft tissue sarcoma.
    Cantwell BM, Carmichael J, Ghani S, Harris AL.
    Cancer Chemother Pharmacol; 1988 Mar 01; 21(1):49-52. PubMed ID: 3124971
    [Abstract] [Full Text] [Related]

  • 11. A Phase I trial of ifosfamide and paclitaxel with granulocyte-colony stimulating factor in the treatment of patients with refractory solid tumors.
    Bunnell CA, Thompson L, Buswell L, Berkowitz R, Muto M, Sheets E, Shulman LN.
    Cancer; 1998 Feb 01; 82(3):561-6. PubMed ID: 9452275
    [Abstract] [Full Text] [Related]

  • 12. A phase II study of ifosfamide in combination with etoposide and cisplatin in the treatment of extensive small cell lung cancer.
    Evans WK, Stewart D, Logan D, Maroun J, Goss G, Shepherd FA, Latreille J, Warner E, Dahrouge S.
    Semin Oncol; 1992 Dec 01; 19(6 Suppl 12):51-6. PubMed ID: 1336622
    [Abstract] [Full Text] [Related]

  • 13. Ifosfamide/etoposide and mesna uroprotection in advanced breast cancer.
    Manegold C, Worst P, Bickel J, Schmid H, Drings P, Kaufmann M.
    Cancer Chemother Pharmacol; 1990 Dec 01; 26 Suppl():S87-90. PubMed ID: 2112056
    [Abstract] [Full Text] [Related]

  • 14. Ambulatory continuous infusion ifosfamide with oral etoposide in advanced sarcomas.
    Skubitz KM, Hamdan H, Thompson RC.
    Cancer; 1993 Nov 15; 72(10):2963-9. PubMed ID: 8221562
    [Abstract] [Full Text] [Related]

  • 15. The multidrug resistant phenotype in clinical practice; evaluation of cross resistance to ifosfamide and mesna after VP16-213, doxorubicin and vincristine (VPAV) for small cell lung cancer.
    Cantwell BM, Bozzino JM, Corris P, Harris AL.
    Eur J Cancer Clin Oncol; 1988 Feb 15; 24(2):123-9. PubMed ID: 2833398
    [Abstract] [Full Text] [Related]

  • 16. High-dose ifosfamide by infusion with Mesna in advanced refractory sarcomas.
    Güllü I, Yalçin S, Tekuzman G, Barişta I, Alkiş N, Celik I, Zengin N, Güler N, Kars A, Baltali E.
    Cancer Invest; 1996 Feb 15; 14(3):239-42. PubMed ID: 8630686
    [Abstract] [Full Text] [Related]

  • 17. Phase II study of cisplatin, ifosfamide with mesna, and etoposide (PIE) chemotherapy for advanced non-small cell lung cancer.
    Shirinian M, Lee JS, Dhingra HH, Greenberg J, Hong WK.
    Semin Oncol; 1992 Feb 15; 19(1 Suppl 1):49-53. PubMed ID: 1329212
    [Abstract] [Full Text] [Related]

  • 18. Ifosfamide/mesna. A review of its antineoplastic activity, pharmacokinetic properties and therapeutic efficacy in cancer.
    Dechant KL, Brogden RN, Pilkington T, Faulds D.
    Drugs; 1991 Sep 15; 42(3):428-67. PubMed ID: 1720382
    [Abstract] [Full Text] [Related]

  • 19. Ifosfamide and vinorelbine as first-line chemotherapy for advanced non-small cell lung carcinoma.
    Vallejo C, Romero A, Perez J, Cuevas M, Lacava J, Sabatini C, Dominguez M, Rodriguez R, Barbieri M, Romero Acuña L, Romero Acuña J, Langhi M, Amato S, Salvadori M, Ortiz E, Machiavelli M, Leone B.
    Am J Clin Oncol; 1996 Dec 15; 19(6):584-8. PubMed ID: 8931677
    [Abstract] [Full Text] [Related]

  • 20. Dana-Farber Cancer Institute studies in advanced sarcoma.
    Antman KH, Elias A.
    Semin Oncol; 1990 Feb 15; 17(1 Suppl 2):7-15. PubMed ID: 2106162
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.